NewcelX Ltd. (NCEL)
NASDAQ: NCEL · Real-Time Price · USD
3.640
+0.030 (0.83%)
At close: Dec 5, 2025, 4:00 PM EST
3.330
-0.310 (-8.52%)
After-hours: Dec 5, 2025, 5:40 PM EST
NewcelX Employees
As of December 31, 2024, NewcelX had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees increased by 3 or 25.00% compared to the previous year.
Employees
15
Change (1Y)
3
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,232,679
Market Cap
16.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15 | 3 | 25.00% |
| Dec 31, 2023 | 12 | -19 | -61.29% |
| Dec 31, 2022 | 31 | -1 | -3.13% |
| Dec 31, 2020 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NCEL News
- 18 days ago - NewcelX Strengthens Scientific Advisory Board with Appointment of Jeremy Shefner, MD, PhD, Chief Medical Officer at the Barrow Neurological Institute - PRNewsWire
- 4 weeks ago - NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board - PRNewsWire
- 4 weeks ago - NewcelX CEO Issues Letter to Shareholders - PRNewsWire
- 4 weeks ago - NewcelX Provides Business and Strategic Roadmap Update Following Closing of Merger with NLS Pharmaceutics Ltd. - PRNewsWire